Skip to main content
. 2024 Jun 1;109(6):1700–1712. doi: 10.3324/haematol.2023.283815

Table 2.

Targeted antibodies in ongoing clinical trials in pediatric acute lymphoblastic leukemia.

graphic file with name 1091700.tab2.jpg